MUSK and myasthenia gravis: Toward developing an antigen-specific treatment for MuSK-MG, we have attempted to develop an oral tolerance approach by feeding with recombinant MuSK-protein, by a similar protocol employed by us previously (11, 12) oral tolerance induction in AChR-EAMG.